Potential cytotoxicity of truncated slow skeletal muscle troponin T ( ssTnT ) in a loss of function TNNT1 myopathy mouse model
The FEBS Journal · 2025
DOI: 10.1111/febs.70165 ↗At a glance
Journal article in The FEBS Journal, 2025. Written by Han-Zhong Feng and 2 co-authors. Institution: Department of Physiology and Biophysics, University of Illinois at Chicago, IL, USA. Major MEDLINE topics: Troponin T, Muscle, Skeletal, Myopathies, Nemaline. Cited 1 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (original language)
A nonsense mutation in codon Glu 180 of the TNNT1 gene, which encodes the slow skeletal muscle isoform of troponin T (ssTnT), causes a recessively inherited myopathy (the Amish Nemaline Myopathy, ANM). A ssTnT knockout (ssTnT‐KO) mouse model produced the loss of ssTnT function phenotypes of ANM with slow fiber atrophy and decreased fatigue resistance of soleus muscle. We further developed a Tnnt1 p.Glu180* knock‐in (ANM‐KI) mouse model to precisely mimic the human mutation. In addition to reproducing the loss of function phenotypes, ANM‐KI mice exhibit more severe myopathy than that of ssTnT‐KO mice. Compared with wild‐type controls, ANM‐KI and ssTnT‐KO soleus muscles show different changes in gene expression profiles, of which gene ontology analysis indicated inflammatory activation in ANM‐KI soleus muscle. The mutant Tnnt1 mRNA was readily detectable in ANM‐KI soleus muscle. However, the truncated ssTnT 1–179 fragment cannot be detected in western blot, indicating its very low level due to the active proteolytic clearance of non‐myofilament‐incorporated TnT in muscle cells. Nonetheless, the more severe myopathic impacts of the ANM‐KI allele with more fiber number loss and muscle activity/injury‐caused hypertrophy support a potent cytotoxicity of the ssTnT fragment, as shown in previous cell culture studies, which is further supported by activity‐dependent and age‐progressing myopathy with more active regeneration. The notion that non‐myofilament‐incorporated ssTnT fragments may potentially contribute to the pathogenesis and progression of myopathy merits further investigation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology and Biophysics, University of Illinois at Chicago, IL, USA.
- Clinic for Special Children, Gordonville, PA, USA.
ORCID profiles: Jian-Ping Jin
Funding
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Feng, H. Z., Strauss, K. A., & Jin, J. P. (2025). Potential cytotoxicity of truncated slow skeletal muscle troponin T ( ssTnT ) in a loss of function TNNT1 myopathy mouse model. The FEBS Journal. https://doi.org/10.1111/febs.70165
Vancouver
Feng HZ, Strauss KA, Jin JP. Potential cytotoxicity of truncated slow skeletal muscle troponin T ( ssTnT ) in a loss of function TNNT1 myopathy mouse model. The FEBS Journal. 2025. doi:10.1111/febs.70165
BibTeX
@article{Feng2025,
author = {Feng, Han-Zhong and Strauss, Kevin A and Jin, Jian-Ping},
title = {Potential cytotoxicity of truncated slow skeletal muscle troponin T ( ssTnT ) in a loss of function TNNT1 myopathy mouse model},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70165}
}
EUVIMED